Johan M. Spoor is CEO at Perspective Therapeutics, Inc. (CATX). They have made 11 open-market trades across 3 companies since 2011, most recently 2025-03-28.
CIK 0001535289
11 open-market purchases totalling $474K since 2011, never a sale. Across 5 scored buys the stock is up 18.9% at ninety days, and 14.2 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 20% | 40% | 60% |
| Avg Move | +2.6% | +7.4% | +18.9% |
| Alpha | +2.4% | +5.3% | +14.2% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CATX | BUY | 2025-03-28 | 2025-04-01 | $2.23 | $60K | -4.4% | +21.1% | +68.6% |
| CATX | BUY | 2024-12-04 | 2024-12-04 | $3.77 | $30K | -8.7% | -7.9% | -38.3% |
| CATX | BUY | 2024-11-25 | 2024-11-26 | $3.79 | $100K | -18.0% | -28.5% | -40.7% |
| CATX | BUY | 2024-06-13 | 2024-06-13 | $1.17 | $117K | -26.3% | -4.3% | +21.3% |
| AZRX | BUY | 2018-12-28 | 2019-01-02 | $1.30 | $100K | +70.5% | +56.8% | +83.5% |
| FPMI | BUY | 2014-01-07 | 2014-01-08 | $0.50 | $5K | N/A | N/A | N/A |
| FPMI | BUY | 2012-11-26 | 2012-11-27 | $0.76 | $8K | N/A | N/A | N/A |
| FPMI | BUY | 2012-09-12 | 2012-09-12 | $0.80 | $40K | N/A | N/A | N/A |
| FPMI | BUY | 2012-08-03 | 2012-08-03 | $0.84 | $4K | N/A | N/A | N/A |
| FPMI | BUY | 2012-06-15 | 2012-06-15 | $0.82 | $5K | N/A | N/A | N/A |
| FPMI | BUY | 2011-11-18 | 2011-11-21 | $1.00 | $5K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.